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Abstract 
Objectives: The aim of this systematic review was to summarize the results concerning the use of simvastatin for 
promoting bone regeneration and to discuss the level of scientific evidence supporting such findings.
Material and Methods: A Pubmed search using “Simvastatin”[Mesh] AND “Bone Regeneration”[Mesh] as Boolean 
operators was constrained to the last 10 years and only included papers written in English.
Results: Of the 41 relevant papers reviewed, most of them (76.2%) have been published in the last 5 years, and 
most of them address animal studies (66.6%) performed on rats or rabbits in extraoral regions. Only 4 randomized 
controlled trials (RCTs) assessed the role of topical simvastatin in periodontal patients.
Conclusions: A large part of the evidence concerning the role of topical simvastatin on bone regeneration comes 
from animal studies (mainly rats) focusing on extraoral bone defects. Only the use of subgingival simvastatin after 
root scaling has been properly supported by RCT. 
Key words: Simvastatin, bone regeneration, topical administration, osteogenesis, osteoinduction.
Montero J, Manzano G, Albaladejo A. The role of topical simvastatin on 
bone regeneration: A systematic review. J Clin Exp Dent. 2014;6(3):e286-
90.
http://www.medicinaoral.com/odo/volumenes/v6i3/jcedv6i3pi.pdf
Article Number: 51415                http://www.medicinaoral.com/odo/indice.htm
© Medicina Oral S. L. C.I.F. B 96689336 - eISSN: 1989-5488
eMail:  jced@jced.es
Indexed in:
Pubmed
Pubmed Central® (PMC)
Scopus
DOI® System
doi:10.4317/jced.51415
http://dx.doi.org/10.4317/jced.51415
Introduction
Since the popularization of dental implants, clinicians 
have found themselves in circumstances in which they 
are forced to place implants in areas where the quality, 
quantity and topography of bone substrate are clearly 
unfavorable. In addition, several regenerative strategies 
have been proposed with the aim of preserving the alve-
olar process after tooth extraction (1) or for augmenting 
bone support for dental implants (2). Thus, the demand 
for effective biomaterials for bone augmentation proce-
dures is currently increasing owing to the disadvantages 
of using autogenous bone graft material, such as limited 
bone availability, additional morbidity at the donor site, 
the impossibility of storage, and the need for general 
anesthesia for extraoral donor sites (3). In light of this, 
researchers are now searching for bone graft materials 
with improved osteogenic properties, with the advan-
tages of autologous bone grafts [osteogenesis, osteoin-
duction and osteoconduction], but without their disad-
vantages [donor site morbidity, difficulty of storage and 
maintenance, unlimited availability, etc.].
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keywords simvastatin and bone regeneration, obtaining 
75 results. In addition, to limit the search results we used 
the following search strategy: “Simvastatin” [Mesh] and 
“Bone Regeneration” [Mesh], constraining the search 
to papers written only in English and published in the 
last 10 years obtaining 37 relevant hits. This search was 
complemented with a manual search of 4 relevant ar-
ticles cited among the previously selected papers. The 
41 papers were revised in depth, and their main findings 
have been summarized throughout the result and discus-
sion sections, discussing current knowledge and noting 
future trends based on the level of evidence. The distri-
bution of such 41 revised papers according to the date of 
publication and the study design is shown in Table 1.
Results
Regarding study design (Table 1), it is to be noted that 
most of the revised papers [76.2%] have been published 
in the last 5 years, most of them involving animal stu-
dies [66.6%] performed on rats or rabbits in extraoral 
regions. To date, only one research team led by Pradeep 
has carried out 4 well-performed randomized clinical 
trials demonstrating that locally- administered simvas-
tatin, versus placebo, significantly improves the clinical 
outcomes of scaling and root planing for treating man-
dibular buccal Class II furcation defects (17) and in pa-
tients with chronic periodontitis (18), even when they 
are smokers (19) or suffer from type 2 diabetes (20).
The in vitro studies have reported that simvastatin seems 
to stimulate bone formation significantly (21) and also 
aids in periodontal regeneration (22).
Studies focusing on pharmacological development have 
tested several biodegradable polymeric formulas for the 
local delivery of simvastatin, which is water-insoluble, 
such as a hydrogel of gelatin (23) or microspheres of po-
ly-lactide-co-glycolide (24), although some carriers tes-
ted also seem to be able to release several bone-forming 
biomolecules simultaneously (25).
Regarding animal studies, it should be noted that most 
of them have been carried out in extraoral regions of rats 
(Table 1) (26-33). The large majority of these studies re-
ported favorable results concerning topical application 
of simvastatin, either injected alone (31) or in combina-
tion with biomaterials (28), or for coating implants (26) 
or covering acellular scaffolds (32). However, this os-
teogenic effect has also been observed when simvastatin 
was administered systemically by means of a 5mg/kg 
daily intraperitoneal (30) or oral  dose (33).
In addition, most animal studies performed intraorally 
have reported good results for topical simvastatin admi-
nistration in enhancing bone regeneration in rat mandi-
bular defects (34) and periodontal lesions in rats [7,35], 
Beagles (36) and minipigs (37).
Nevertheless, other authors have reported unfavourable 
results after using simvastatin for bone formation. Pauly 
Alloplastic bone substitutes have been combined with 
different molecules for the efficient induction of bone 
formation. In 1965, Urist used hydrochloric acid for the 
demineralization of bone matrix and observed ectopic 
bone formation after the implantation of demineralized 
bone matrix within the soft tissues, calling this process 
bone formation by autoinduction (4). It was not until 
1980 that the same author reported the identification in 
the rat organic bone matrix of an insoluble protein of 
low molecular weight called Bone Morphogenetic Pro-
tein [BMP] (5). However, the use of BMPs entails some 
problems such as their short life, storage and handling 
difficulties, inefficiency in the recognition of target cells, 
and high cost. This has hampered their popularization in 
bone regeneration procedures (6).
On searching for alternatives to the application of these 
exogenous genetically engineered proteins, some authors 
have suggested the topical use of drug compounds aimed 
at upregulating intrinsic bone growth factors. For ex-
ample, some widely known pharmacologic compounds 
[such as bisphosphonates or statins] have recently been 
shown to upregulate bone growth through distinct and 
complex biochemical pathways (7,8). Along this line, in 
1999 Mundy et al. (9) were the first authors to report that 
lovastatin and simvastatin stimulate bone regeneration 
when injected subcutaneously in mouse calvaria. Since 
then, a huge development of research focusing on clini-
cal applications has occurred in traumatology (10), oral 
surgery (11), and periodontology (12).
Simvastatin is one of the most commonly prescribed 
drugs for the treatment of hypercholesterolemia because 
it prevents the synthesis of cholesterol (13). In addition 
to its lipid-lowering effects, simvastatin can also elicit 
some pleiotropic effects, leading to the modulation of 
the process of bone regeneration at the molecular and 
cellular levels (14). Simvastatin seems to play an impor-
tant role in bone regeneration by participating directly 
in osteoblast activation [increasing BMP-2 expression]
and in osteoclast inhibition (15), and also indirectly, by 
stimulating neovascularization [increasing the secretion 
of Vascular Endothelial Growth Factor] (16).
The biological feasibility and the biochemical pathways 
of topical simvastatin in bone regeneration have been 
reviewed recently (14), but the current level of evidence 
concerning regenerative applications of simvastatin has 
not been established in a systematic way.
Objectives
The aim of this systematic review was to summarize the 
results on the use of simvastatin for promoting bone re-
generation and to discuss the level of scientific evidence 
supporting such findings.
Material and Methods 
In October 2013, we made a search in Pubmed using as 
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et al. (27) reported impaired integration of intramedulary 
titanium implants coated with simvastatin after 8 weeks 
of healing in rat femurs. In the same sense, Lima et al. 
(38) found a negative impact of combining simvastatin 
with demineralized bovine bone matrix for repairing 
calvarial defects in rats after 30 to 60 days of healing. 
In agreement with these studies on rats, in other studies 
performed on rabbits the authors failed to find any clear 
improvement on using topical simvastatin in osteoin-
ductive activity for the short-term repair of nasal bone 
defects (15) or for enhancing mandibular distraction, 
even when applied both locally during the osteotomy 
phase, and systemically during the distraction osteoge-
nesis period (11). Anbinder et al. also found that simvas-
tatin administration, either orally or subcutaneously, did 
not improve bone repair for experimental tibial defects 
in rats (39). Rutledge et al. reported only minor effects 
of locally injected simvastatin for inducing new bone 
formation in the jaw bone of dogs (40).
Discussion
Autologous bone is still the current gold-standard graft 
material for the treatment of bone defects (2). However, 
the need for a second surgical site, the limited supply of 
bone available, and the impossibility of storage have led 
to the development of different alternative bone substi-
tutes. These biomaterials have also been combined with 
different bioactive agents as an appealing cost-effective 
way to promote bone formation. Statins [lovastatin, flu-
vastatin and simvastatin] have been demonstrated to mo-
dulate bone growth when applied locally (14). However, 
both clinicians and researchers are still in need of an 
updated evidence-based review of such promising rege-
nerative applications in the field. This study summarizes 
the main findings of the investigations in which simvas-
tatin was used to stimulate bone regeneration, and, to 
our knowledge, is the first systematic review addressing 
this topic. We focused only on simvastatin, since it is 
the statin most widely applied for this purpose, although 
other statins have also been investigated.
In light of our summarized results, the use of topical 
simvastatin for bone regeneration can be seen as a re-
latively recent research line, since most studies have 
been carried out in the last 5 years. The majority of the 
studies reviewed here were performed on small mam-
mals [mainly rats but also rabbits], and generally in ex-
traoral regions, reporting mainly favourable results for 
several bone surgical procedures. This shows that this 
research line is still in its initial stages. It should be taken 
into account that the different rates of bone turn-over 
in mammals, and throughout the bones of a given spe-
cies, would hamper the extrapolation of such findings 
to the human mouth. Nevertheless 4 RCT were found 
with the search strategy used here. The fact that such 
well-designed trials were all performed at the same cen-
tre [Government Dental College and Research Institute 
of Bangalore, India] and by the same research team led 
by Pradeep could be a cause of concern. Those authors 
demonstrated a significant improvement in the clinical 
and radiographic parameters when a flowable gel of si-
mvastatin [1.2mg/0.1ml] was injected at sites treated by 
scaling and root planing among different profiles of pe-
riodontal patients (17-20). Unfortunately no other pro-
mising application drawn from animal studies, such as 
the use of topical simvastatin for coating implants, or 
bone substitutes or acellular scaffolds, has been addres-
sed in clinical trials. Therefore, the above data should 
encourage researchers and clinicians to replicate the for-
mulation of the methylcellulose-based simvastatin gel 
described by Pradeep et al. (17-20) in order to check cli-
nical outcomes in other settings or applications. It seems 
relatively simple to randomize and mask this interven-
tion by a placebo gel, and it would not be very difficult 
to access the active principle since it is commercialized.
Caution should be exercised regarding the dosing of 
the simvastatin, since several authors have reported a 
dose-dependent inflammatory response (28). In animal 
studies, a 0.1-0.5 mg dose of simvastatin would be the 
optimal dose for stimulating maximum bone regenera-
tion without inducing inflammation (37). According to 
Pradeep et al. (17-20), for humans the topical dose of 
simvastatin did not produce any complications or adver-
se reactions. Regarding the carrier used by Pradeep et 
al, methylcellulose was probably chosen for operational 
reasons [it is extensively used as a sustained-released 
vehicle for therapeutic formulations]; however, other 
polymeric carriers could also offer some advantages, 
such as a slower release of the molecules, or even multi-
ple drug carriers (23-25). 
Future efforts should be directed towards understan-
ding the biological mechanisms underlying why a sin-
gle topical application of simvastatin in a subgingival 
environment is able to act as an anti-inflammatory and 
Table 1. Distribution of the reviewed papers according to the study design (n=41). 
Period Articles
N(%)
In Vitro 
Studies
Pharmacological 
development
ANIMAL STUDIES RCT
Rats Rabbits Dogs/minipigs 
Intraoral Extraoral Intraoral Extraoral Intraoral Extraoral
2008-2013 32 (76.2) 3 (7.3) 3(7.3) 3(7.3) 10(24.4) 1(2.4) 4(9.8) 3(7.3) 1(2.4) 4(9.8)
2002-2007 9 (23.8) 0 2(4.9) 2(4.9) 3(7.3) 0 2(4.9) 0 0 0
TOTAL 41 (100.0) 3(7.3) 5(12.2) 5(12.2) 13(31.7) 1(2.4) 6(14.6) 3(7.3) 1(2.4) 4(9.8)
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regenerative agent of periodontal-tissues 6 to 9 months 
later, presumably affording a long-term effect (17-20). 
In light of several contradictory reports, it also remains 
unclear whether the oral consumption of statins has any 
significant effect on bone regeneration and periodontal 
health. 
Long-term, multicenter, randomized, controlled clinical 
trials will be required to properly assess the effect of to-
pical simvastatin in bone regeneration for many diffe-
rent indications.
Conclusions
Most of the evidence regarding the role of topical si-
mvastatin on bone regeneration, comes from animal stu-
dies [mainly rats], focusing on extraoral bone defects. 
However 4 well-designed RCT have reported signifi-
cantly better clinical outcomes when a flowable gel of 
simvastatin [1.2mg/0.1ml] was injected at sites treated 
previously with scaling and root planing in periodontal 
patients. No other application has been properly asses-
sed in humans.
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